Leishmania donovani BPK282A1 complete genome, chromosome 22.
Eukaryota; Euglenozoa; Kinetoplastida; Trypanosomatidae; Leishmaniinae; Leishmania.
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
Submitted (30-MAR-2018) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA
Submitted (25-JAN-2011) Aslett M., Pathogen Sequencing Unit, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, Cambridgeshire CB10 1SA, UNITED KINGDOM
PROVISIONAL REFSEQ: This record has not yet been subject to final\nNCBI review. The reference sequence is identical to FR799609.\nData release policy http://www.sanger.ac.uk/legal/#t_2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: INSDC submitter\nAnnotation Status :: Full annotation\nAnnotation Pipeline :: Eukaryotic Annotation Propagation Pipeline\n##Genome-Annotation-Data-END##
carnitine palmitoyltransferase-like protein
methylenetetrahydrofolate dehydrogenase-like protein
proteasome regulatory ATPase subunit 1, putative
ubiquitin-conjugating enzyme-like protein
proteasome regulatory ATPase subunit 5, putative
small nuclear ribonucleoprotein, putative
adaptor complex AP-1 medium subunit, putative
translation initiation factor IF-2, putative
ribonucleoside-diphosphate reductase small chain, putative
intraflagellar transport protein-like protein
Serine-threonin protein phosphatase, putative
ATP-dependent DEAD/H RNA helicase, putative
exosome complex exonuclease RRP45 homolog, putative
phosphoinositide-specific phospholipase C, putative